Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 116

  • Showing results for bizarre leiomyoma pathology. Your search for Bizarre leiomyoma patholgy retrieved no results.
2.

Low-grade endometrial stromal sarcoma combined with leiomyoma (stromomyoma): A bizarre tumor of the uterus in a premenopausal woman.

Yenicesu O, Tokmak A, Sirvan AL, Danisman N, Güngör T.

J Exp Ther Oncol. 2018 Nov;12(4):281-286.

PMID:
30476382
3.

Loss of ATRX/DAXX expression and alternative lengthening of telomeres in uterine leiomyomas.

Ahvenainen TV, Mäkinen NM, von Nandelstadh P, Vahteristo MEA, Pasanen AM, Bützow RC, Vahteristo PM.

Cancer. 2018 Dec 15;124(24):4650-4656. doi: 10.1002/cncr.31754. Epub 2018 Nov 13.

PMID:
30423196
4.

Fumarate hydratase (FH) deficiency in uterine leiomyomas: recognition by histological features versus blind immunoscreening.

Siegler L, Erber R, Burghaus S, Brodkorb T, Wachter D, Wilkinson N, Bolton J, Stringfellow H, Haller F, Beckmann MW, Hartmann A, Agaimy A.

Virchows Arch. 2018 May;472(5):789-796. doi: 10.1007/s00428-018-2292-6. Epub 2018 Jan 13.

PMID:
29332133
5.

MVP immunohistochemistry is a useful adjunct in distinguishing leiomyosarcoma from leiomyoma and leiomyoma with bizarre nuclei.

Lintel NJ, Luebker SA, Lele SM, Koepsell SA.

Hum Pathol. 2018 Mar;73:122-127. doi: 10.1016/j.humpath.2017.12.020. Epub 2018 Jan 4.

PMID:
29307622
6.

The selected biomarker analysis in 5 types of uterine smooth muscle tumors.

Zhang Q, Kanis MJ, Ubago J, Liu D, Scholtens DM, Strohl AE, Lurain JR, Shahabi S, Kong B, Wei JJ.

Hum Pathol. 2018 Jun;76:17-27. doi: 10.1016/j.humpath.2017.12.005. Epub 2017 Dec 16.

PMID:
29258902
7.

Prevalence of occult leiomyosarcomas and atypical leiomyomas after laparoscopic morcellation of leiomyomas in reproductive-age women.

Pados G, Tsolakidis D, Theodoulidis V, Makedos A, Zaramboukas T, Tarlatzis B.

Hum Reprod. 2017 Oct 1;32(10):2036-2041. doi: 10.1093/humrep/dex258.

PMID:
28938732
8.

Symplastic epididymal leiomyoma with bizarre cytology.

Raghavendran M, Venugopal A, Kumar KG.

Cytopathology. 2017 Dec;28(6):549-551. doi: 10.1111/cyt.12464. Epub 2017 Sep 3. No abstract available.

PMID:
28868647
9.

Fumarate Hydratase Mutations and Alterations in Leiomyoma With Bizarre Nuclei.

Zhang Q, Poropatich K, Ubago J, Xie J, Xu X, Frizzell N, Kim J, Kong B, Wei JJ.

Int J Gynecol Pathol. 2018 Sep;37(5):421-430. doi: 10.1097/PGP.0000000000000447.

PMID:
28863073
10.

Cotyledonoid Dissecting Leiomyoma with Symplastic Features: Case Report.

Sonmez FC, Tosuner Z, Karasu AFG, Arıcı DS, Dansuk R.

Rev Bras Ginecol Obstet. 2017 Aug;39(8):436-440. doi: 10.1055/s-0037-1604057. Epub 2017 Aug 7.

11.

Leiomyoma With Bizarre Nuclei: Clinical and Pathologic Features of 30 Patients.

Kefeli M, Caliskan S, Kurtoglu E, Yildiz L, Kokcu A.

Int J Gynecol Pathol. 2018 Jul;37(4):379-387. doi: 10.1097/PGP.0000000000000425.

PMID:
28700441
12.

Leiomyoma with bizarre nuclei: a morphological, immunohistochemical and molecular analysis of 31 cases.

Bennett JA, Weigelt B, Chiang S, Selenica P, Chen YB, Bialik A, Bi R, Schultheis AM, Lim RS, Ng CKY, Morales-Oyarvide V, Young RH, Reuter VE, Soslow RA, Oliva E.

Mod Pathol. 2017 Oct;30(10):1476-1488. doi: 10.1038/modpathol.2017.56. Epub 2017 Jun 30.

13.

Primary inferior vena cava smooth muscle tumor with diffuse bizarre giant nuclei and low mitotic rate: a nomenclatural conundrum.

Chetty R, Kalimuthu SN, Heinonen HR.

Cardiovasc Pathol. 2017 Sep - Oct;30:1-5. doi: 10.1016/j.carpath.2017.05.007. Epub 2017 Jun 4.

PMID:
28623706
14.

Immunoexpression of p16 in uterine leiomyomas with infarct-type necrosis: an analysis of 35 cases.

Ip PP, Lim D, Cheung ANY, Oliva E.

Histopathology. 2017 Nov;71(5):743-750. doi: 10.1111/his.13282. Epub 2017 Aug 14.

PMID:
28609585
15.

Characterization of MED12, HMGA2, and FH alterations reveals molecular variability in uterine smooth muscle tumors.

Mäkinen N, Kämpjärvi K, Frizzell N, Bützow R, Vahteristo P.

Mol Cancer. 2017 Jun 7;16(1):101. doi: 10.1186/s12943-017-0672-1.

16.

The mitosis-specific marker phosphohistone-H3 (PHH3) is an independent prognosticator in uterine smooth muscle tumours: an outcome-based study.

Chow KL, Tse KY, Cheung CL, Wong KW, Cheung AN, Wong RW, Chan AN, Yuen NW, Ngan HY, Ip PP.

Histopathology. 2017 Apr;70(5):746-755. doi: 10.1111/his.13124. Epub 2017 Jan 24.

PMID:
27864989
17.

Exploring chromosomal abnormalities and genetic changes in uterine smooth muscle tumors.

Liegl-Atzwanger B, Heitzer E, Flicker K, Müller S, Ulz P, Saglam O, Tavassoli F, Devouassoux-Shisheboran M, Geigl J, Moinfar F.

Mod Pathol. 2016 Oct;29(10):1262-77. doi: 10.1038/modpathol.2016.107. Epub 2016 Jul 1.

18.

Bizarre leiomyoma of uterus/smooth muscle tumor of uncertain malignant potential: A diagnostic dilemma.

Swami SY, Ganjewar RD, Gaikwad S, Girji DD.

Indian J Cancer. 2015 Oct-Dec;52(4):697-8. doi: 10.4103/0019-509X.178418. No abstract available.

19.

Immunohistochemical Profile of Uterine Leiomyoma With Bizarre Nuclei; Comparison With Conventional Leiomyoma, Smooth Muscle Tumors of Uncertain Malignant Potential and Leiomyosarcoma.

Dastranj Tabrizi A, Ghojazadeh M, Thagizadeh Anvar H, Vahedi A, Naji S, Mostafidi E, Berenjian S.

Adv Pharm Bull. 2015 Dec;5(Suppl 1):683-7. doi: 10.15171/apb.2015.093. Epub 2015 Dec 31.

20.

Practical issues in uterine pathology from banal to bewildering: the remarkable spectrum of smooth muscle neoplasia.

Oliva E.

Mod Pathol. 2016 Jan;29 Suppl 1:S104-20. doi: 10.1038/modpathol.2015.139. Review.

Supplemental Content

Loading ...
Support Center